2 min read
MRHA Guidance for Clinical Trials During COVID-19 Outbreak
MHRA Guidance On Clinical Trial Conduct During COVID-19 Pandemic
Blog | Think Bold, Think Scientific, Think Veristat
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
8 min read
Regulatory Insights on COVID-19 Updates From FDA | 31 March 2020
March 23, 2020
FDA UPDATES - For Sponsors with Products Intended to Treat Indications Other than COVID-19
In this unique time, with many health authorities, governments and pharmaceutical companies focused on the global pandemic and how to prevent, diagnose and...
2 min read
Covid-19 Update from FDA | Conduct of Clinical Trials During Covid-19 Outbreak
March 19, 2020
FDA Guidance On Clinical Trial Conduct During COVID-19 Pandemic - 18 March 2020
3 min read
Regulatory Guidance Monthly Review - February 2020
March 3, 2020
February 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...